We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Wireless Monitoring Facilitates Cardiac Patient Management

By HospiMedica International staff writers
Posted on 22 Dec 2015
A new remote cardiac rhythm monitor incorporates complete mobile cardiac telemetry (MCT), Holter, and cellular event monitoring. More...


The 3-1 TeleSense device is a comfortable to wear, simple to set up, and configurable device for the auto-detection of arrhythmia events and concomitant wireless transmission of three-channel electrocardiogram (ECG) data, thus allowing clinicians to more accurately correlate between patient symptoms and changes in the electrical conduction of the heart. A web-accessible platform supports detailed and actionable reporting through daily event reports, heart rate trends reports, and end-of-session reports; interim and summary statistics; and advanced administrative and clinical queries.

The device can transmit up to 30 days of continuous ECG data across multiple cellular networks or by utilizing a patient’s own WiFi network. For clinicians unable to offer patients 24-hour monitoring coverage, an optional dedicated monitoring service provides active daily surveillance and reporting capabilities, as well as immediate access to raw data and completed reports from any internet connected computer. Optional electronic health record (EHR) integration enables reports to be easily viewed and e-signed by the physician prior to automated transmission.

Brightly-lit icons allow the patient to easily identify whether the device has sufficient power, whether leads are properly connected, if the device is recording, and the status of the WiFi or cellular connection. Patients can also quickly record and immediately transmit self-identified events via a large, easily accessible button on the front of the device, helping to address the continuous concern of patient compliance. The 3-1 TeleSense device is a product of ScottCare (Cleveland, OH, USA).

“We created TeleSense with the goal of providing clinicians with an easy-to-use, comprehensive monitoring device they could trust for diagnostic accuracy, technological reliability and improved patient compliance,” said Sneh Merchant, vice president of research and development at ScottCare. “They can depend on TeleSense to help them care for their cardiac event patients in a highly convenient and effective way.”

Related Links:

ScottCare



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.